Adrian Rabin
Lawyers
Associate in our IP, Tech & Commercial Transactions practice.
Experience highlights
Recent Representations
- Smith+Nephew acquisition of CartiHeal
- Sealed Air $425 million senior notes offering and concurrent tender offer
- Newfold Digital Holdings Group $515 million senior secured notes offering
- Immedica Pharma acquisition of pegzilarginase assets from Aeglea
- Korro Bio $117 million private placement
- Oculis Holding $40.25 million debut equity offering
- Seagate HDD Cayman $1 billion senior notes offering
- Emergent BioSolutions $150 million at-the-market offering
- ACELYRIN $621 million IPO
- Gamida Cell $23 million follow-on offering
- AVITA Medical at-the-market offering
- Medtronic Global Holdings $2 billion notes offering
- Revolution Medicines $345 million follow-on offering
- Precigen $75 million follow-on offering
- Metalmark Capital up to $50 million investment in Morgenesis
- Medtronic Global Holdings €3.5 billion notes offering
Education
J.D., Cornell Law School
- Online Editor, Cornell International Law Journal
B.A., Biology, Emory University
Professional history
- Davis Polk since 2022
Qualifications and admissions
- State of New York
- U.S. District Court, S.D. New York